DOSE SELECTION BY PREDICTION OF HUMAN ORAL CLEARANCE OF FTY 720 USING INTERSPECIES SCALING
Elizabeth Migoya(Hochschule Hannover), Robert Schmouder(Novartis (United States)), Mark T. Marino(Hochschule Hannover), P Lücker(Hochschule Hannover), Neumayer Hh(Hochschule Hannover), L Brookman(Novartis (Switzerland)), S Choudhury(Hochschule Hannover), R. Brunkhorst(Klinikum Region Hannover)
Cited by 2
Related Papers
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
|Intensive Care Medicine|2007|623
First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients
|Journal of the American Society of Nephrology|2002|274